A perspective on DNA microarrays in pathology research and practicePOLLACK, Jonathan R.The American journal of pathology. 2007, Vol 171, Num 2, pp 375-385, issn 0002-9440, 11 p.Article

DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression dataSALARI, Keyan; TIBSHIRANI, Robert; POLLACK, Jonathan R et al.Bioinformatics (Oxford. Print). 2010, Vol 26, Num 3, pp 414-416, issn 1367-4803, 3 p.Article

Characterizing the physical genomePOLLACK, Jonathan R; IYER, Vishwanath R.Nature genetics. 2002, Vol 32, Num DEC, pp 515-521, issn 1061-4036, 7 p., SUPArticle

Gene expression profiling in prostate cancer cells with Akt activation reveals Fra-1 as an Akt-inducible geneTIWARI, Gunjan; SAKAUE, Hiroshi; POLLACK, Jonathan R et al.Molecular cancer research. 2003, Vol 1, Num 6, pp 475-484, issn 1541-7786, 10 p.Article

Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and ProliferationDI CAI; SHAMES, David S; NANJUNDAN, Meera et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 16, pp 6477-6485, issn 0008-5472, 9 p.Article

hCAP-D3 Expression Marks a Prostate Cancer Subtype With Favorable Clinical Behavior and Androgen Signaling SignatureLAPOINTE, Jacques; MALHOTRA, Sameer; VAN DE RIJN, Matt et al.The American journal of surgical pathology. 2008, Vol 32, Num 2, pp 205-209, issn 0147-5185, 5 p.Article

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesisLAPOINTE, Jacques; CHUNDE LI; GIACOMINI, Craig P et al.Cancer research (Baltimore). 2007, Vol 67, Num 18, pp 8504-8510, issn 0008-5472, 7 p.Article

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown originTOTHILL, Richard W; KOWALCZYK, Adam; SUTHERLAND, Robert L et al.Cancer research (Baltimore). 2005, Vol 65, Num 10, pp 4031-4040, issn 0008-5472, 10 p.Article

REGULARIZED MULTIVARIATE REGRESSION FOR IDENTIFYING MASTER PREDICTORS WITH APPLICATION TO INTEGRATIVE GENOMICS STUDY OF BREAST CANCER : Network modelingJIE PENG; JI ZHU; BERGAMASCHI, Anna et al.The Annals of applied statistics. 2010, Vol 4, Num 1, pp 53-77, issn 1932-6157, 25 p.Article

An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AMLBULLINGER, Lars; DÖHNER, Konstanze; POLLACK, Jonathan R et al.Blood. 2008, Vol 111, Num 9, pp 4490-4495, issn 0006-4971, 6 p.Article

Identification of Candidate Prostate Cancer Genes Through Comparative Expression-Profiling of Seminal VesicleTHOMPSON, Maxwell; LAPOINTE, Jacques; CHOI, Yoon-La et al.The Prostate. 2008, Vol 68, Num 11, pp 1248-1256, issn 0270-4137, 9 p.Article

Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemiaBULLINGER, Lars; RÜCKER, Frank G; GANSER, Arnold et al.Blood. 2007, Vol 110, Num 4, pp 1291-1300, issn 0006-4971, 10 p.Article

Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterizationRÜCKER, Frank G; BULLINGER, Lars; RADLWIMMER, Bernhard et al.Journal of clinical oncology. 2006, Vol 24, Num 24, pp 3887-3894, issn 0732-183X, 8 p.Article

The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancerKIM, Hanna; LAPOINTE, Jacques; KAYGUSUZ, Gulsah et al.Cancer research (Baltimore). 2005, Vol 65, Num 18, pp 8118-8124, issn 0008-5472, 7 p.Article

Challenges in developing a molecular characterization of cancerPOLLACK, Jonathan R; VAN DE RIJN, Matt; BOTSTEIN, David et al.Seminars in oncology. 2002, Vol 29, Num 3, pp 280-285, issn 0093-7754Article

MYC stimulates EZH2 expression by repression of its negative regulator miR-26aSANDER, Sandrine; BULLINGER, Lars; KLAPPROTH, Kay et al.Blood. 2008, Vol 112, Num 10, pp 4202-4212, issn 0006-4971, 11 p.Article

A gene expression signature of genetic instability in colon cancerGIACOMINI, Craig P; SUET YI LEUNG; XIN CHEN et al.Cancer research (Baltimore). 2005, Vol 65, Num 20, pp 9200-9205, issn 0008-5472, 6 p.Article

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancerAMANN, Joseph; KALYANKRISHNA, Shailaja; KIM, Young H et al.Cancer research (Baltimore). 2005, Vol 65, Num 1, pp 226-235, issn 0008-5472, 10 p.Article

Comparative genomic hybridization on mouse cDNA microarrays and its application to a murine lymphoma modelSANDER, Sandrine; BULLINGER, Lars; KARLSSON, Asa et al.Oncogene (Basingstoke). 2005, Vol 24, Num 40, pp 6101-6107, issn 0950-9232, 7 p.Article

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemiaBULLINGER, Lars; DÖHNER, Konstanze; BAIR, Eric et al.The New England journal of medicine. 2004, Vol 350, Num 16, pp 1605-1616, issn 0028-4793, 12 p.Article

Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberansLINN, Sabine C; WEST, Rob B; BOTSTEIN, David et al.The American journal of pathology. 2003, Vol 163, Num 6, pp 2383-2395, issn 0002-9440, 13 p.Article

Molecular characterisation of soft tissue tumours: a gene expression studyNIELSEN, Torsten O; WEST, Rob B; BROWN, Patrick O et al.Lancet (British edition). 2002, Vol 359, Num 9314, pp 1301-1307, issn 0140-6736Article

Development of an Orthotopic Model of Invasive Pancreatic Cancer in an Immunocompetent Murine HostTSENG, William W; WINER, Daniel; KENKEL, Justin A et al.Clinical cancer research (Print). 2010, Vol 16, Num 14, pp 3684-3695, issn 1078-0432, 12 p.Article

KIT mutations confer a distinct gene expression signature in core binding factor leukaemiaLÜCK, Sonja C; RUSS, Annika C; JUAN DU et al.British journal of haematology. 2010, Vol 148, Num 6, pp 925-937, issn 0007-1048, 13 p.Article

LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast CancerCHOI, Yoon-La; BOCANEGRA, Melanie; MI JEONG KWON et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 6, pp 2296-2306, issn 0008-5472, 11 p.Article